PositiveID Corporation (fka PSID)

[AMOTE1]

PositiveID Investor Update: Continuing to Improve Its FireflyDx Product Due Diligence for Investors in PositiveID Corp.
Designed for Investors
Nov 11 2015

PositiveID Investor Update: Continuing to Improve Its FireflyDx Product
Due Diligence for Investors in PositiveID Corp.
We linked the PSID press release from November 10th that describes improvement to the FireflyDx allowing it to detect lower levels of airborne pathogens. We also linked the PSID form 8-K that gives the details of the intended acquisition of Thermomedics and their Caregiver temperature detection device. The barchart.com analysis will give the current data and key statistics for PSID along with the current charting and analysis.
Our View: The combination of the improved FireflyDx and Caregiver technologies takes PSID to a new level in the pathogen and disease threat detection arena.
Caregiver was utilized recently by both government and commercial customers in the fight against the spread of Ebola. The infra-red non-touch nature of the device allows for fast and effective temperature monitoring of large groups of people. Thermomedics has agreements with the world’s leading healthcare product distributors and that could make the marketing and distribution of the FireflyDx easier.
The case for Thermomedics acquisition has clear benefit for PSID: 1.Caregiver is already generating revenue. 2. Thermomedics has experience with the FDA. 3. Thermomedics already has established distribution channels. 4. Thermomedics has manufacturing experience. 5. The human temperature monitoring market is experiencing explosive growth.